Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-087802
Filing Date
2025-09-16
Accepted
2025-09-15 19:45:28
Documents
19
Effectiveness Date
2025-09-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0256955-s8_adlai.htm S-8 60392
2 OPINION OF MAPLES AND CALDER (HONG KONG) LLP, REGARDING THE VALIDITY OF THE SECU ea025695501ex5-1_adlai.htm EX-5.1 11562
3 ADLAI NORTYE LTD. 2025 SHARE INCENTIVE PLAN ea025695501ex10-1_adlai.htm EX-10.1 110404
4 CONSENT OF BDO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP ea025695501ex23-2_adlai.htm EX-23.2 2735
5 CONSENT OF MAZARS USA LLP ea025695501ex23-3_adlai.htm EX-23.3 1803
6 CALCULATION OF FILING FEE TABLE ea025695501ex-fee_adlai.htm   iXBRL EX-FILING FEES 13286
7 GRAPHIC ex5-1_001.jpg GRAPHIC 9431
8 GRAPHIC ex5-1_002.jpg GRAPHIC 212300
9 GRAPHIC ex23-2_001.jpg GRAPHIC 38817
  Complete submission text file 0001213900-25-087802.txt   679919

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT ea025695501ex-fee_adlai_htm.xml XML 4315
Mailing Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902
Business Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902 848-230-7430
Adlai Nortye Ltd. (Filer) CIK: 0001944552 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290280 | Film No.: 251315445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)